Search Results - Khisimuzi Mdluli
- Showing 1 - 20 results of 20
-
1
-
2
-
3
-
4
-
5
-
6
Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis by Si-Yang Li, Rokeya Tasneen, Sandeep Tyagi, Heena Soni, Paul J. Converse, Khisimuzi Mdluli, Eric L. Nuermberger
Published 2017Artigo -
7
-
8
Biochemical and Genetic Data Suggest that InhA Is Not the Primary Target for Activated Isoniazid in Mycobacterium tuberculosis by Khisimuzi Mdluli, David R. Sherman, Mark J. Hickey, Barry N. Kreiswirth, S.M. Morris, C. Kendall Stover, Clifton E. Barry
Published 1996Artigo -
9
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model by Si‐Yang Li, Paul J. Converse, Fabrice Betoudji, Jin Lee, Khisimuzi Mdluli, Anna M. Upton, Nader Fotouhi, Eric L. Nuermberger
Published 2023Artigo -
10
Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis by Kathy N. Williams, Austin Minkowski, Opokua Amoabeng, Charles A. Peloquin, Dinesh Taylor, Koen Andries, Robert S. Wallis, Khisimuzi Mdluli, Eric L. Nuermberger
Published 2012Artigo -
11
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis by Ian M. Rosenthal, Rokeya Tasneen, Charles A. Peloquin, Ming Zhang, Deepak V. Almeida, Khisimuzi Mdluli, Petros C. Karakousis, J Grosset, Eric L. Nuermberger
Published 2012Artigo -
12
-
13
<i>In Vitro</i> and <i>In Vivo</i> Activities of the Nitroimidazole TBA-354 against Mycobacterium tuberculosis by Anna M. Upton, Sang‐Hyun Cho, Tianjian Yang, Y. Kim, Yong Wang, Yu Lu, B. Wang, Jian Xu, Khisimuzi Mdluli, Zhenkun Ma, Scott G. Franzblau
Published 2014Artigo -
14
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis by Jian Xu, Si-Yang Li, Deepak V. Almeida, Rokeya Tasneen, Kala Barnes-Boyle, Paul J. Converse, Anna M. Upton, Khisimuzi Mdluli, Nader Fotouhi, Eric L. Nuermberger
Published 2019Artigo -
15
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis by Rokeya Tasneen, Fabrice Betoudji, Sandeep Tyagi, Si-Yang Li, Kathy N. Williams, Paul J. Converse, Véronique Dartois, Tian J. Yang, Carl M. Mendel, Khisimuzi Mdluli, Eric L. Nuermberger
Published 2015Artigo -
16
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis by Scott G. Franzblau, Mary Ann DeGroote, Sang‐Hyun Cho, Koen Andries, Eric L. Nuermberger, Ian M. Orme, Khisimuzi Mdluli, Íñigo Angulo‐Barturen, Thomas Dick, Véronique Dartois, Anne J. Lenaerts
Published 2012Revisão -
17
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis by Si‐Yang Li, Sandeep Tyagi, Heena Soni, Fabrice Betoudji, Paul J. Converse, Khisimuzi Mdluli, Anna M. Upton, Nader Fotouhi, David Barros-Aguirre, Lluís Ballell, Elena Jiménez‐Navarro, Eric L. Nuermberger
Published 2024Artigo -
18
Molecular Validation of LpxC as an Antibacterial Drug Target in <i>Pseudomonas aeruginosa</i> by Khisimuzi Mdluli, Pamela R. Witte, Toni Kline, Adam W. Barb, Alice L. Erwin, Bryce E. Mansfield, Amanda L. McClerren, Michael C. Pirrung, L. Nathan Tumey, Paul Warrener, Christian R.H. Raetz, C. Kendall Stover
Published 2006Artigo -
19
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis Treatment by Eric L. Nuermberger, María Santos Martínez, Olalla Sanz, Beatriz Urones, Jorge Esquivias, Heena Soni, Rokeya Tasneen, Sandeep Tyagi, Si‐Yang Li, Paul J. Converse, Helena I. Boshoff, Gregory T. Robertson, Gurdyal S. Besra, Katherine A. Abrahams, Anna M. Upton, Khisimuzi Mdluli, Gary W. Boyle, Sam Turner, Nader Fotouhi, N. Cammack, Juan Miguel Siles, Marta Alonso, Jaime Escribano, Joël Lelièvre, Joaquin Rullas-Trincado, Esther Pérez‐Herrán, Robert H. Bates, Gareth Maher-Edwards, David Barros, Lluís Ballell, Elena Jiménez
Published 2022Artigo -
20
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens by Nicholas D. Walter, Sarah E. M. Born, Gregory T. Robertson, Matthew J. Reichlen, Christian Dide-Agossou, Victoria Ektnitphong, Karen Rossmassler, Michelle E. Ramey, Allison Bauman, Victor Ozols, Shelby C. Bearrows, Gary K. Schoolnik, Gregory Dolganov, Benjamin J. Garcia, Emmanuel Musisi, William Worodria, Laurence Huang, J. Lucian Davis, Nguyen Viet Nhung, Hung Van Nguyen, Nguyễn Thị Vân Anh, Ha Phan, Carol J. Wilusz, Brendan K. Podell, N Sanoussi, Bouke C. de Jong, Corinne Merle, Dissou Affolabi, Helen McIlleron, Maria Garcia‐Cremades, Ekaterina Maidji, Franceen Eshun‐Wilson, Brandon Aguilar-Rodriguez, Dhuvarakesh Karthikeyan, Khisimuzi Mdluli, Cathy Bansbach, Anne J. Lenaerts, Radojka M. Savić, Payam Nahid, Joshua Vasquez, Martin I. Voskuil
Published 2021Artigo
Search Tools:
Related Subjects
Biology
Medicine
Mycobacterium tuberculosis
Pathology
Tuberculosis
Pharmacology
Microbiology
Genetics
Bedaquiline
Regimen
Internal medicine
Bacteria
Antibiotics
Biochemistry
Drug
Isoniazid
Pyrazinamide
Immunology
Linezolid
Staphylococcus aureus
Vancomycin
Chemistry
Drug resistance
Virology
Clofazimine
Ethambutol
Gene
Leprosy
Moxifloxacin
Bioinformatics